| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2016 | NEO Neogenomics Inc | Albitar Maher | Chief Medical Officer | Sell | 105,300 | $8.20 | $863,460.00 | -100% | |
| Sep 20, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $10.36 | $18,648.00 | - | |
| Sep 19, 2016 | RDNT Radnet, Inc. | Forthuber Stephen M49 | Executive Vice President | Sell | 20,000 | $7.18 | $143,600.00 | -4.8% | |
| Sep 19, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $10.18 | $18,324.00 | - | |
| Sep 16, 2016 | XWEL Xwell, Inc. | Abbe Richard | Director | Buy | 21,600 | $2.64 | $56,952.72 | +11.3% | |
| Sep 15, 2016 | XWEL Xwell, Inc. | Abbe Richard | Director | Buy | 8,300 | $2.45 | $20,307.61 | +4.5% | |
| Sep 14, 2016 | XWEL Xwell, Inc. | Bernstein Bruce58 | Director | Buy | 11,430 | $2.10 | $24,001.86 | +106.8% | |
| Sep 14, 2016 | XWEL Xwell, Inc. | Abbe Richard | Director | Buy | 24,041 | $2.14 | $51,368.40 | +7.3% | |
| Sep 13, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $9.95 | $99,530.00 | - | |
| Sep 13, 2016 | BIO Bio-Rad Laboratories, Inc. | Stark James R | VP, Corporate Controller | Sell | 76 | $158.09 | $12,014.84 | -6.1% | |
| Sep 13, 2016 | BIO Bio-Rad Laboratories, Inc. | Magni Giovanni | EVP, Chief Strategy Officer | Sell | 92 | $158.07 | $14,542.66 | -0.7% | |
| Sep 13, 2016 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 127 | $158.09 | $20,077.43 | -4.2% | |
| Sep 13, 2016 | BIO Bio-Rad Laboratories, Inc. | Hall Shannon | Executive Vice President | Sell | 92 | $158.08 | $14,543.28 | -6.9% | |
| Sep 13, 2016 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 228 | $158.08 | $36,042.90 | -2.2% | |
| Sep 12, 2016 | RVTY Revvity, Inc. | Tereau Daniel R69 | Please See Remarks | Sell | 18,866 | $52.00 | $981,032.00 | -76.1% | |
| Sep 12, 2016 | XWEL Xwell, Inc. | Abbe Richard | Director | Buy | 152,005 | $2.11 | $320,755.05 | +133.9% | |
| Sep 12, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $9.79 | $97,868.50 | - | |
| Sep 12, 2016 | XWEL Xwell, Inc. | Perlman Andrew D | Chief Executive Officer | Buy | 23,250 | $2.16 | $50,173.50 | +34.4% | |
| Sep 12, 2016 | XWEL Xwell, Inc. | Bernstein Bruce58 | Director | Buy | 10,700 | $2.10 | $22,468.93 | New | |
| Sep 12, 2016 | BIO Bio-Rad Laboratories, Inc. | Hall Shannon | Executive Vice President | Sell | 414 | $155.02 | $64,177.00 | -27.5% | |
| Sep 12, 2016 | BIO Bio-Rad Laboratories, Inc. | Stark James R | VP, Corporate Controller | Sell | 269 | $155.02 | $41,699.41 | -20.4% | |
| Sep 12, 2016 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 523 | $155.02 | $81,075.20 | -16.2% | |
| Sep 12, 2016 | NEO Neogenomics Inc | Albitar Maher | Chief Medical Officer | Sell | 60,075 | $8.23 | $494,123.25 | -18.7% | |
| Sep 12, 2016 | MYGN Myriad Genetics Inc | Henderson John T65 | Director | Sell | 30,000 | $20.49 | $614,816.29 | -41.1% | |
| Sep 12, 2016 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 3,417 | $157.81 | $539,250.38 | -15.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.